The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Background: While tuberculosis incidence and mortality are declining in South Africa, meeting the goals of the End TB Strategy requires an invigorated programmatic response informed by accurate data. Enumerating the losses at each step in the care cascade enables appropriate targeting of interventions and resources. Methods: We estimated the tuberculosis burden; the number and proportion of individuals with tuberculosis who accessed tests, had tuberculosis diagnosed, initiated treatment, and successfully completed treatment for all tuberculosis cases, for those with drug-susceptible tuberculosis (including human immunodeficiency virus (HIV)-coinfected cases) and rifampicin-resistant tuberculosis. Estimates were derived from national electronic tuberculosis register data, laboratory data, and published studies. Results: The overall tuberculosis burden was estimated to be 532005 cases (range, 333760-764480 cases), with successful completion of treatment in 53% of cases. Losses occurred at multiple steps: 5% at test access, 13% at diagnosis, 12% at treatment initiation, and 17% at successful treatment completion. Overall losses were similar among all drug-susceptible cases and those with HIV coinfection (54% and 52%, respectively, successfully completed treatment). Losses were substantially higher among rifampicin- resistant cases, with only 22% successfully completing treatment. Conclusion: Although the vast majority of individuals with tuberculosis engaged the public health system, just over half were successfully treated. Urgent efforts are required to improve implementation of existing policies and protocols to close gaps in tuberculosis diagnosis, treatment initiation, and successful treatment completion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Estimated tuberculosis incidence and mortality in South Africa and projected sustainable development goals and End TB Strategy targets. Data on the estimated tuberculosis incidence rates and mortality for 2000 to 2015 are from the revised time series analysis of global tuberculosis burden published by the World Health Organization in 2016 [4]. Projected figures for 2030–2035 are based on targets relative to the 2015 estimates and assume a straight-line decline in tuberculosis incidence rates and mortality in this period.](https://figures.cochat.ai/paper-figures/757956bc09674e5dac1f9369b4ea93c6/the-south-african-tuberculosis-care-cascade-estimated-losses-and-methodological-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only half of all patients with TB complete treatment and less than two-thirds with HIV achieve virological suppression on antiretroviral therapy (ART), with rates even lower among individuals with SU and other behavioral health concerns like depression (Naidoo et al., 2017; Zuma et al., 2022).”
From Siyakhana: A Hybrid Type 2 Effectiveness-Implementation Stepped-Wedge Trial to Reduce Stigma Towards Substance Use and Depression Among Community Health Workers in HIV/TB Care in South Africa (2025) · cites this paper as Naidoo et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“contribute to poor engagement in HIV and TB care in South Africa”
From Siyakhana: A Hybrid Type 2 Effectiveness-Implementation Stepped-Wedge Trial to Reduce Stigma Towards Substance Use and Depression Among Community Health Workers in HIV/TB Care in South Africa (2025) · cites this paper as Naidoo et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
A systematic review of delay in the diagnosis and treatment of tuberculosis
Storla, D. G., Yimer, S., & Bjune, G. A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-15 · Cited by 1,018
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013 · cited 2×
“The remainder were tested by less sensitive smear microscopy [13].”
BackgroundFluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Steingart, K. R., Henry, M., Ng, V., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70578-3 · Cited by 798 · cited 1×
“Smear sensitivity in HIV-positive: 50% (42%–57%) [13, 14] Proportion with culture performed: HIV-positive/Xpert-negative, 14%; HIV-”
BackgroundTiemersma, E. W., van der Werf, M. J., Borgdorff, M. W., Williams, B. G., & Nagelkerke, N. J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017601 · Cited by 583
Inequities in access to health care in South Africa
Harris, B., Goudge, J., Ataguba, J. E., McIntyre, D., Nxumalo, N., Jikwana, S., & Chersich, M. (2011) · Journal of Public Health Policy · doi:10.1057/jphp.2011.35 · Cited by 502
Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature
Sreeramareddy, C. T., Panduru, K. V., Menten, J., & Van den Ende, J. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-91 · Cited by 455
Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Self-citationGenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis
Ling, D. I., Zwerling, A. A., & Pai, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00061808 · Cited by 340
Research works printed but not linked: 4
- World Health Organization (WHO). Global tuberculosis report 2016. Geneva: WHO, 2016.
- World Health Organization. The End TB Strategy. Geneva, Switzerland: WHO, 2015.
- World Health Organization (WHO). WHO treatment guidelines for drug-resistant tuberculosis. Geneva, Switzerland: WHO, 2016.
- Health Systems Trust. District health barometer 2014/2015. 2015. Available at: http://www.hst.org.za/publications/District%20Health%20Barometers/Complete_DHB_2014_15_linked.pdf. Accessed 6 October 2016.
Cited by
High-quality health systems in the Sustainable Development Goals era: time for a revolution
Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Adeyi, O., Barker, P., Daelmans, B., Doubova, S. V., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30386-3 · Cited by 4,057
Furin, J., Cox, H., & Pai, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30308-3 · Cited by 873
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Drug-resistant tuberculosis: a persistent global health concern
Farhat, M., Cox, H., Ghanem, M., Denkinger, C. M., Rodrigues, C., Abd El Aziz, M. S., Enkh-Amgalan, H., Vambe, D., Ugarte-Gil, C., Furin, J., et al. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01025-1 · Cited by 242
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes
Togun, T., Kampmann, B., Stoker, N. G., & Lipman, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00363-1 · Cited by 233
Metadata
- Authors
- Naidoo, P., Theron, G., Rangaka, M. X., Chihota, V. N., Vaughan, L., Brey, Z. O., & Pillay, Y.
- Affiliations
- Gates Foundation (US)
- Stellenbosch University (ZA)
- University of Cape Town (ZA)
- University of the Witwatersrand (ZA)
- Department of Health (ZA)
- Corresponding author
- Naidoo, Pren
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-01
- Volume
- 216
- Issue
- suppl_7
- Pages
- S702-S713
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC5853316
- OpenAlex
- W2767345805
- Cited by
- 238
- References
- 54
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 26 · 2023: 23 · 2022: 32 · 2021: 38 · 2020: 43 · 2019: 32 · 2018: 18 · 2017: 2
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- United States Agency for International Development (AIDOAAA1000021)
- Bill and Melinda Gates Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- treatment completion, rifampicin-resistant tuberculosis, HIV/TB coinfection, drug-susceptible tuberculosis, tuberculosis diagnosis, treatment initiation, End TB Strategy, South Africa
- MeSH terms
- Antibiotics, Antitubercular, Antitubercular Agents, Community Health Services, Patient Care, Humans, Mycobacterium tuberculosis, Rifampin, South Africa, Tuberculosis, HIV Infections, Incidence, Treatment Outcome, Cost of Illness, Tuberculosis, Multidrug-Resistant, Drug Resistance, Multiple, Bacterial, Black People, Lost to Follow-Up, Coinfection, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges. https://app.cochat.ai/papers/10.1093/infdis/jix335
- The paper
- Naidoo, P., Theron, G., Rangaka, M. X., Chihota, V. N., Vaughan, L., Brey, Z. O., & Pillay, Y. (2017). The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jix335
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.